SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-14-001716
Filing Date
2014-01-13
Accepted
2014-01-10 17:59:42
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v365078_10qa.htm 10-Q/A 1300196
2 EXHIBIT 31.1 v365078_ex31-1.htm EX-31.1 17297
3 EXHIBIT 31.2 v365078_ex31-2.htm EX-31.2 17326
4 EXHIBIT 32.1 v365078_ex32-1.htm EX-32.1 9060
5 EXHIBIT 32.2 v365078_ex32-2.htm EX-32.2 8973
  Complete submission text file 0001144204-14-001716.txt   8508611

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20130930.xml EX-101.INS 1234737
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20130930.xsd EX-101.SCH 84147
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20130930_cal.xml EX-101.CAL 32205
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20130930_def.xml EX-101.DEF 382846
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20130930_lab.xml EX-101.LAB 495755
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20130930_pre.xml EX-101.PRE 464292
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 14522790
SIC: 2834 Pharmaceutical Preparations